Calcium channel blockers versus other classes of drugs for hypertension
Author:
Affiliation:
1. Department of Neurology; West China Hospital, Sichuan University; Chengdu China
2. Epidemic Disease & Health Statistics Department; School of Public Health, Sichuan University; Chengdu China
3. China
Publisher
Wiley
Subject
Pharmacology (medical)
Reference135 articles.
1. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial;Agodoa;JAMA,2001
2. Effect of blood pressure control and antihypertensive drug regimen on quality of life: The African American Study of Kidney Disease and Hypertension (AASK) Pilot Study;Kusek;Controlled Clinical Trials,1996
3. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial;Norris;American Journal of Kidney Diseases,2006
4. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial;Wright;JAMA,2002
5. Design and baseline characteristics of participants in the African American Study of Kidney disease and hypertension (AASK) pilot study;Wright;Controlled Clinical Trials,1996
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A REVERSE PHASE ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY-PHOTO DIODE ARRAY ESTIMATION OF CAPTOPRIL AND HYDROCHLOROTHIAZIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM;International Journal of Applied Pharmaceutics;2024-07-07
2. Update of the clinical guideline for hypertension diagnosis and treatment in Iran;Clinical Hypertension;2024-06-01
3. Strategies to prevent, diagnose and treat kidney disease related to systemic arterial hypertension: a narrative review from the Mexican Group of Experts on Arterial Hypertension;BMC Nephrology;2024-01-18
4. Calcium channel blockers and clinical outcomes in patients with continuous‐flow left ventricular assist devices;ESC Heart Failure;2023-11-15
5. Mebudipine as an Overlooked Cardioprotective Drug: A Review Study;Annals of Military and Health Sciences Research;2023-11-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3